AMANDA SIMPSON: Open Payments
NPI 1316163595 · DAYTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,651 in 85 payments from 13 companies in 2025. Trend: 2023 $116 · 2024 $364 · 2025 $1,651
Food & beverage: $1,651
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $496 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 16 | $262 |
| Janssen Biotech, Inc. | 11 | $235 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $154 |
| Celltrion USA Inc. | 5 | $110 |
| GENZYME CORPORATION | 2 | $103 |
| Lilly USA, LLC | 4 | $91 |
| Aimmune Therapeutics, Inc. | 3 | $62 |
| Ardelyx, Inc. | 2 | $49 |
| Novo Nordisk Inc | 2 | $39 |
Products named: XIFAXAN, TREMFYA, CREON, SKYRIZI, RINVOQ, VEGZELMA, DUPIXENT, OMVOH.
Industry payments across OH — which companies pay providers there.
